Haurwitz Rachel E. 13D and 13G filings for Caribou Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-06 4:06 pm Purchase |
2023-07-18 | 13D | Caribou Biosciences, Inc. CRBU |
Haurwitz Rachel E. | 4,378,913 4.800% |
757,594 (+20.92%) |
Filing |
| 2022-02-04 09:00 am Purchase |
2022-02-01 | 13D | Caribou Biosciences, Inc. CRBU |
Haurwitz Rachel E. | 3,621,319 6.000% |
3,621,319 (New Position) |
Filing |